Bank of America’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.1M | Buy |
|
|||||
|
2025
Q1 | $22.8M | Buy |
|
|||||
|
2024
Q4 | $5.21M | Sell |
|
|||||
|
2024
Q3 | $6.91M | Sell |
|
|||||
|
2024
Q2 | $10.4M | Buy |
|
|||||
|
2024
Q1 | $7.71M | Buy |
|
|||||
|
2023
Q4 | $3.52M | Sell |
|
|||||
|
2023
Q3 | $3.99M | Sell |
|
|||||
|
2023
Q2 | $8.18M | Sell |
|
|||||
|
2023
Q1 | $17.6M | Buy |
|
|||||
|
2022
Q4 | $3.76M | Buy |
|
|||||
|
2022
Q3 | $2.61M | Buy |
|
|||||
|
2022
Q2 | $2.43M | Buy |
|
|||||
|
2022
Q1 | $5.87M | Buy |
|
|||||
|
2021
Q4 | $4.09M | Buy |
|
|||||
|
2021
Q3 | $1.02M | Sell |
|
|||||
|
2021
Q2 | $2.95M | Buy |
|
|||||
|
2021
Q1 | $1.08M | Buy |
|
|||||
|
2020
Q4 | $271K | Sell |
|
|||||
|
2020
Q3 | $1.19M | Buy |
|
|||||
|
2020
Q2 | $129K | Sell |
|
|||||
|
2020
Q1 | $55K | Buy |
|
|||||
|
2019
Q4 | $52K | Sell |
|
|||||
|
2019
Q3 | $118K | Buy |
|
|||||
|
2019
Q2 | $100K | Sell |
|
|||||
|
2019
Q1 | $583K | Buy |
|
|||||
|
2018
Q4 | $178K | Buy |
|
|||||
|
2018
Q3 | $140K | Sell |
|
|||||
|
2018
Q2 | $143K | Buy |
|
|||||
|
2018
Q1 | $7K | Sell |
|
|||||
|
2017
Q4 | $33K | Buy |
|
|||||
|
2017
Q3 | $11K | Buy |
|
|||||
|
2017
Q2 | $0 | Sell |
|
|||||
|
2017
Q1 | $17K | Buy |
|
|||||
|
2016
Q4 | $23K | Buy |
|